ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
about
Associations of ACE gene insertion/deletion polymorphism, ACE activity, and ACE mRNA expression with hypertension in a Chinese populationLosartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental GlaucomaThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.Conformational changes of blood ACE in chronic uremia.New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibitionExercise intensity modulates capillary perfusion in correspondence with ACE I/D modulated serum angiotensin II levelsThe angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exerciseIndividualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk ModelInterlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.Urinary markers of intrarenal renin-angiotensin system activity in vivo.Functional Proteomic Profiling of Phosphodiesterases Using SeraFILE Separations Platform.Renal angiotensin-converting enzyme upregulation: a prerequisite for nitric oxide synthase inhibition-induced hypertension?Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?The Metabolic Response of Skeletal Muscle to Endurance Exercise Is Modified by the ACE-I/D Gene Polymorphism and Training State.Effects of green tea, black tea and Rooibos tea on angiotensin-converting enzyme and nitric oxide in healthy volunteers.ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.ACE polymorphisms and the acute response of blood pressure to a walk in medicated hypertensive patients.Apolipoprotein B and angiotensin-converting enzyme polymorphisms and aerobic interval training: randomized controlled trial in coronary artery disease patients.ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathyCommentaries on Viewpoint: Epigenetic regulation of the ACE gene might be more relevant to endurance physiology than the I/D polymorphism
P2860
Q28533961-30B004CB-04B8-4881-957D-455586A99E95Q28550525-5AB580BD-6ADE-46BE-A55F-92A6BDDD065AQ30486745-03E80F92-9E9F-4EC5-8AB6-BF8C605754A8Q34482175-B3D3D4CD-4582-4159-9427-10736B2D080AQ35137270-6DD4A8DE-6D0C-45E3-9A62-DD9EDF28AA73Q35137560-9019816A-9F34-4333-A018-0564151FF599Q36556409-4A7D304D-A912-42D3-9539-E4E7C7CCBF59Q36917085-DF989C0C-902E-41C1-9C33-2246D0E6DA43Q37090714-B5B2D3BE-BB64-4899-A3F9-06EDDFD02956Q37142875-0456B7A0-D323-4458-B3DC-7237F6383F2CQ38072329-1E79A193-E378-40F4-AF72-BD60017949DDQ39228918-9CAD85ED-E2E1-411C-97FD-314359F09EDFQ43030392-B9F8BB41-FF87-473C-A4AC-76CD5FE44EF5Q43031194-AA33B30F-7D6B-46A7-B59E-BD00F637CD17Q45915296-655837D9-474D-426F-91CE-C1478AFB2A5CQ47221984-D3E56DBD-6B7E-47D8-B199-168E5963460BQ50565249-DA20D39D-A842-44D9-B53F-97D9BB5E6E8FQ50956599-2DB41CF4-CEEB-42F0-A93A-3AE1FEA7D7F0Q53677177-BFA9810A-1B12-4AB1-B7F2-365204B177A5Q55300111-DAE398A9-3EB4-4F9E-AF07-B061692E77D3Q58362610-E2CFE0A2-0F75-442F-AD2D-2F5C56CF1AE3Q58458570-4C676BBF-ECE2-4557-857C-C49694943FAB
P2860
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
ACE phenotyping as a first ste ...... ic efficacy of ACE inhibition?
@ast
ACE phenotyping as a first ste ...... ic efficacy of ACE inhibition?
@en
type
label
ACE phenotyping as a first ste ...... ic efficacy of ACE inhibition?
@ast
ACE phenotyping as a first ste ...... ic efficacy of ACE inhibition?
@en
prefLabel
ACE phenotyping as a first ste ...... ic efficacy of ACE inhibition?
@ast
ACE phenotyping as a first ste ...... ic efficacy of ACE inhibition?
@en
P2093
P1476
ACE phenotyping as a first ste ...... ic efficacy of ACE inhibition?
@en
P2093
A H Jan Danser
Anton H van den Meiracker
Sergei M Danilov
Wendy W Batenburg
P304
P356
10.1016/J.PHARMTHERA.2006.12.001
P577
2006-12-28T00:00:00Z